Skip to main content
. Author manuscript; available in PMC: 2015 Jul 5.
Published in final edited form as: Eur J Pharmacol. 2014 Apr 12;734:98–104. doi: 10.1016/j.ejphar.2014.04.004

Table 4.

Pharmacokinetic properties of VN/14-1 (oral vs intravenous)

Route Dose Cmax (mg/ml) tmax (h) t1/2 (h) AUC (0-∞) (h*mg/ml) Bioavailability
Oral (20 mg/kg) 38.2 0.50 1.41 93.9 1.34
Intravenous (20 mg/kg) 107 - 0.98 70.3

Pharmacokinetic parameters of VN/14-1 in female rats after oral or i.v. dose of 20 mg/kg. Cmax maximum plasma concentration, tmax time taken to achieve Cmax, t1/2 elimination half-life, AUC area under the curve.